Poolbeg Pharma (LON:POLB, OTCQB: POLBF) announces a change in Board role and the approval of an Employee Performance Incentive Plan to align objectives and encourage retention. Cathal Friel becomes Executive Chairman, bringing valuable experience from his successful track record in public companies. The plan aims to reward and retain key senior management for sustainable growth.

Related Keywords

Cathal Friel , Poolbeg Pharma , Ian Oconnell , Chiesi Farmaceutici , Amryt Pharma , David Allmond , Jeremy Skillington , John Mcevoy , Remuneration Committee , Remuneration Committee Of The Board , Employee Performance Incentive Plan , Non Executive Chairman , Executive Chairman , Open Orphan , Chief Executive Officer , Chief Financial Officer , Ciano Connell , Chief Business Officer , Legal Officer ,